|1.||Gallez, Bernard: 14 articles (09/2015 - 01/2003)|
|2.||van der Kogel, Albert J: 14 articles (02/2015 - 03/2002)|
|3.||Bussink, Johan: 10 articles (02/2015 - 12/2002)|
|4.||Kaanders, Johannes H A M: 9 articles (10/2013 - 03/2002)|
|5.||Robinson, Simon P: 9 articles (09/2013 - 11/2002)|
|6.||Mitchell, James B: 8 articles (08/2010 - 02/2002)|
|7.||Krishna, Murali C: 8 articles (08/2010 - 02/2002)|
|8.||Hou, Huagang: 7 articles (04/2015 - 11/2002)|
|9.||Grégoire, Vincent: 6 articles (09/2015 - 01/2003)|
|10.||Mason, Ralph P: 6 articles (08/2015 - 07/2002)|
11/01/2014 - "For 9L-gliomas, a significant correlation between (18)F-FAZA T/B ratio and tumor growth delay was found; additionally, carbogen breathing dramatically improved the tumor response to irradiation. "
04/01/2015 - "When compared with pretreatment estimates, treatment with VDA resulted in a significant reduction in the tumor hemodynamic response to carbogen at PAI (P = .030). "
11/15/2001 - "Both normobaric carbogen and HBO significantly improved the radiation response of R1H tumors. "
11/01/1998 - "These results may partially explain why carbogen breathing failed to improve the efficacy of radiation in this tumor model when transplanted subcutaneously."
01/01/1997 - "These findings show that carbogen breathing has potential for increasing the efficacy of anti-cancer drugs. "
12/01/2014 - "Compared with air, carbogen increased arterial blood pO2 5-fold in LDLR(-/-) mice and reduced plaque hypoxia in advanced plaques of the aortic root (-32%) and arch (-84%). "
11/01/2014 - "Potential role of hypoxia imaging using (18)F-FAZA PET to guide hypoxia-driven interventions (carbogen breathing or dose escalation) in radiation therapy."
04/01/2010 - "This enhanced uptake was abrogated by carbogen breathing, indicating that in the absence of physiologic hypoxia, high GLUT-1 expression, by itself, was insufficient to ensure high (18)F-FDG uptake."
02/24/2009 - "Decreases in prostate tumour R(2)* in both animal models and human patients as a result of carbogen inhalation suggests the presence of significant hypoxia. "
03/01/2007 - "Diffusion and carbogen-based hypoxia mapping data were also acquired. "
02/01/2005 - "Intrinsic blood-tissue contrast-functional MRI during carbogen breathing may help detect and characterize prostate carcinoma from normal tissue, particularly in small 1-sided carcinomas. "
05/21/2004 - "Dramatic increases in optical fluence rate were measured at the base of 1-cm-thick subcutaneous EMT6 mammary carcinomas in vivo when the tumour-bearing mouse was subjected to carbogen through a nose cone. "
04/01/2009 - "From 1994 to 2000, a total of 105 consecutive patients with high-grade superficial or muscle-invasive bladder carcinoma were given accelerated radiotherapy (50-55 Gy in 4 weeks) with carbogen alone or ARCON. "
06/01/2005 - "Acute and late morbidity was assessed in 105 patients with high-grade superficial or muscle-invasive bladder carcinoma who were given accelerated radiotherapy (50-55 grays in 4 weeks) with carbogen alone or with ARCON. "
11/01/1996 - "Short communication: a technique for delivering carbogen with high dose rate intraluminal brachytherapy in carcinoma of the oesophagus; early results and toxicity."
11/01/1998 - "The results of this study also demonstrate that MTH increases radiosensitivity with and without carbogen breathing up to 24 h after the mild hyperthermia treatment."
10/01/1999 - "To test the individual and combined effects of local mild temperature hyperthermia (MTH) at 41.5 degrees C for 60 min and carbogen breathing on tumour radiosensitivity. "
10/01/1999 - "Radiosensitization of two murine tumours with mild temperature hyperthermia and carbogen breathing."
04/01/2001 - "However, mild hyperthermia is far more effective than carbogen breathing in increasing the radiation response of experimental tumors, probably because mild hyperthermia oxygenates both (diffusion-limited) chronically hypoxic and (perfusion-limited) acutely hypoxic cells, whereas carbogen breathing oxygenates only the chronically hypoxic cells. "
11/01/1998 - "To determine the most effective combination of carbogen breathing with mild temperature hyperthermia (MTH) to increase the oxygenation and radiation response in murine tumors. "
03/01/2005 - "Flow maps of normal rat brains and those containing a 9L gliosarcoma orthotopic tumor model conditions were acquired with and without carbogen. "
01/01/1995 - "The dose modifying factor produced by the hemoglobin preparation/air was 1.9 and by the hemoglobin preparation/carbogen was 2.9 in the rat 9L gliosarcoma. "
01/01/1995 - "The percent of pO2 readings < or = 5 mmHg in the gliosarcoma was 49%, this was decreased to 24% by administration of the hemoglobin preparation and further decreased to 0% when carbogen breathing was added to administration of the hemoglobin preparation. "
05/29/1995 - "Tissue oxygen tensions were measured in subcutaneously growing rat 9L gliosarcoma under normal air and carbogen breathing conditions prior to and after i.v. administration of a perflubron emulsion. "
01/01/1995 - "Tissue oxygen tensions were measured in the rat 9L gliosarcoma under conditions of normal air breathing or carbogen breathing and after intravenous administration of a hemoglobin solution with air breathing or carbogen breathing. "
|5.||perflubron (L 1913)
|6.||tirapazamine (SR 4233)
|2.||Drug Therapy (Chemotherapy)
|3.||Heterologous Transplantation (Xenotransplantation)